Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

Imai, E. ; Chan, J. C. N. ; Ito, S. ; Yamasaki, T. ; Kobayashi, F. ; Haneda, M. ; Makino, H.

Diabetologia, 2011-12, Vol.54 (12), p.2978-2986 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível